145 related articles for article (PubMed ID: 2735661)
1. Effects of dermatan sulfate and heparin on inhibition of thrombus growth in vivo.
Van Ryn-McKenna J; Ofosu FA; Gray E; Hirsh J; Buchanan MR
Ann N Y Acad Sci; 1989; 556():304-12. PubMed ID: 2735661
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.
Ofosu FA; Modi GJ; Smith LM; Cerskus AL; Hirsh J; Blajchman MA
Blood; 1984 Sep; 64(3):742-7. PubMed ID: 6235872
[TBL] [Abstract][Full Text] [Related]
3. Relative efficacy of heparin and related glycosaminoglycans as antithrombotic drugs.
Thomas DP; Merton RE; Barrowcliffe TW
Ann N Y Acad Sci; 1989; 556():313-22. PubMed ID: 2735662
[TBL] [Abstract][Full Text] [Related]
4. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate.
Ofosu FA; Modi GJ; Blajchman MA; Buchanan MR; Johnson EA
Biochem J; 1987 Dec; 248(3):889-96. PubMed ID: 2963622
[TBL] [Abstract][Full Text] [Related]
5. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
[TBL] [Abstract][Full Text] [Related]
6. The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.
Buchanan MR; Boneu B; Ofosu F; Hirsh J
Blood; 1985 Jan; 65(1):198-201. PubMed ID: 3965047
[TBL] [Abstract][Full Text] [Related]
7. The haemorrhagic and antithrombotic effects of dermatan sulphate.
Fernandez F; Van Ryn J; Ofosu FA; Hirsh J; Buchanan MR
Br J Haematol; 1986 Oct; 64(2):309-17. PubMed ID: 3778825
[TBL] [Abstract][Full Text] [Related]
8. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
[TBL] [Abstract][Full Text] [Related]
9. Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli.
Van Ryn-McKenna J; Gray E; Weber E; Ofosu FA; Buchanan MR
Thromb Haemost; 1989 Feb; 61(1):7-9. PubMed ID: 2473537
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
Buchanan MR; Brister SJ
Thromb Res; 2000 Sep; 99(6):603-12. PubMed ID: 10974347
[TBL] [Abstract][Full Text] [Related]
13. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
Scully MF; Ellis V; Seno N; Kakkar VV
Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
[TBL] [Abstract][Full Text] [Related]
15. Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate.
Ofosu FA; Fernandez F; Gauthier D; Buchanan MR
Semin Thromb Hemost; 1985 Apr; 11(2):133-7. PubMed ID: 3898370
[No Abstract] [Full Text] [Related]
16. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.
Ofosu FA; Hirsh J; Esmon CT; Modi GJ; Smith LM; Anvari N; Buchanan MR; Fenton JW; Blajchman MA
Biochem J; 1989 Jan; 257(1):143-50. PubMed ID: 2920007
[TBL] [Abstract][Full Text] [Related]
17. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model.
Maggi A; Abbadini M; Pagella PG; Borowska A; Pangrazzi J; Donati MB
Haemostasis; 1987; 17(6):329-35. PubMed ID: 3428718
[TBL] [Abstract][Full Text] [Related]
19. Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents.
Merton RE; Thomas DP
Thromb Haemost; 1987 Oct; 58(3):839-42. PubMed ID: 3433248
[TBL] [Abstract][Full Text] [Related]
20. Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth in vivo.
Boneu B; Buchanan MR; Cade JF; Van Ryn J; Fernandez FF; Ofosu FA; Hirsh J
Thromb Res; 1985 Oct; 40(1):81-9. PubMed ID: 4089829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
